Compare Estee Lauder Companies Inc (EL) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Estee Lauder Companies Inc vs Oscar Health Inc — how do they compare? Estee Lauder Companies Inc trades at $98.05 (market cap $34.17B), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Estee Lauder Companies Inc is far larger — about 3.3× Oscar Health Inc's market cap, and Estee Lauder Companies Inc pays a 1.48% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Estee Lauder Companies Inc for 122 Days and Oscar Health Inc for 15 Days on average.
| EL | OSCR | |
|---|---|---|
Market Cap | $34.17B | $10.22B |
Volume | 3,921,497 | 4,123,394 |
Sector | Consumer Staples | Health |
52-Week High | $119.61 | $33.81 |
52-Week Low | $67.23 | $10.85 |
Typical Hold Time | 122 Days | 15 Days |
Enterprise Value | $39.92B | $6.57B |
Dividend Yield | 1.48% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Estée Lauder (EL) trades at $98.05, up 3.81% today, with a neutral technical signal and bullish moving averages. The stock has beaten earnings estimates for three consecutive quarters, though it reported a net loss of $1.13 billion in 2025. Analyst consensus is a Buy with a $103.00 price target, and recent news highlights strategic partnerships in AI and leadership changes.
The outlook is mixed: strong gross margins and recent earnings beats support upside, but high valuation ratios and negative net income pose risks. Investor sentiment is cautiously optimistic, driven by digital initiatives and brand strategy, yet competitive pressures and macroeconomic headwinds remain key concerns for sustained growth.
OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.
Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Estee Lauder Companies Inc
Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
Read more on EL →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
